Clinical Trials Browser

OTHER × HER2-positive Breast Cancer × Cyclophosphamide × Clear all

NCT07635342 2026-06-09

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer

Phase 2 Recruiting

HER2-positive Breast Cancer

NCT02379585 2018-04-24

STEFNE

Phase 1/2 Terminated

8 enrolled 1 chart

HER2-positive Breast Cancer